SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001626199-21-000130
Filing Date
2021-09-27
Accepted
2021-09-27 07:02:20
Documents
1
Period of Report
2021-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_163274052780471.html 4/A  
1 FORM 4/A wf-form4a_163274052780471.xml 4/A 4125
  Complete submission text file 0001626199-21-000130.txt   5807
Mailing Address C/O ARCA BIOPHARMA, INC 8001 ARISTA PLACE, STE 430 BROOMFIELD CO 80021
Business Address
CONWAY ROBERT E (Reporting) CIK: 0001184334 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37449 | Film No.: 211278983

Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations